Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1637 1682 1699
This examiner grants 57% of resolved cases
Joseph G. Dauner is an examiner in Tech Center 1600, working in Art Unit 1634. He has 738 resolved cases and an allowance rate of 56.9%. This figure suggests a challenging environment for applicants. However, the interview lift is 35.2%, which is a significant figure showing that interviews are a very effective way to improve the chances of an allowance.
The median days to allowance for this examiner is 1173. This timeline indicates a prosecution cycle of over three years. For practitioners, the 738 resolved cases provide a robust data set for planning. The 56.9% allowance rate and the 35.2% interview lift suggest that applicants should prioritize interviews to overcome hurdles. In Art Unit 1634, the 1173-day median pendency is a key factor for long-term planning, especially given the significant impact of oral advocacy on the final outcome.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18675633 | SYSTEM AND METHOD FOR PREPARATION OF NUCLEOTIDE SOLUTIONS | Non-Final OA | Life Technologies Corporation |
| 18629059 | FLUIDICS SYSTEMS FOR SEQUENTIAL DELIVERY OF REAGENTS | Final Rejection | Life Technologies Corporation |
| 18506885 | METHODS AND COMPOSITIONS FOR MULTIPLEX PCR | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17942887 | ARRAY-BASED METHODS FOR ANALYSING MIXED SAMPLES USING DIFFERENTLY LABELLED ALLELE-SPECIFIC PROBES | Final Rejection | AFFYMETRIX, INC. |
| 17873788 | MULTIPLEXED SPATIAL CAPTURE OF ANALYTES | Non-Final OA | 10x Genomics, Inc. |
| 18563344 | DIAGNOSTIC FOR SEPSIS ENDOTYPES AND/OR SEVERITY | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 17811677 | DETECTING GASTROINTESTINAL NEOPLASMS | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18026287 | HYBRID PROTOCOLS AND BARCODING SCHEMES FOR MULTIPLE SEQUENCING TECHNOLOGIES | Final Rejection | The Regents of the University of California |
| 18498339 | FLAP PROBE AND USE THEREOF | Non-Final OA | TOPPAN INC. |
| 17792612 | METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17908809 | FIT-FLARES FOR DETECTION OF INTRACELLULAR ANALYTES IN LIVE CELLS | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 18261366 | METHODS OF DETECTING HIGH RISK BARRETT'S ESOPHAGUS WITH DYSPLASIA, AND ESOPHAGEAL ADENOCARCINOMA | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 17766489 | TARGETED SEQUENCING TO DETECT AND QUANTIFY LOW LEVELS OF METHYLATED DNA | Final Rejection | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 18554389 | METHODS AND SYSTEMS FOR HPV DETECTION AND QUANTIFICATION | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18504868 | METHODS OF PREDICTING AND TREATING IMMUNOTHERAPY TOXICITY BASED ON IMMUNE CELL POPULATIONS | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18707525 | METHOD FOR PREDICTING REACTIVITY TO ANTICANCER DRUGS BY ANALYZING GENOMIC DNA METHYLATION STATUS | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18700307 | COMPOSITION FOR DIAGNOSING PERIODONTAL DISEASES BY USING BACTERIAL CLUSTERS IN GINGIVAL CREVICULAR FLUID, AND USE THEREOF | Non-Final OA | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18696136 | NUCLEIC ACID CHARACTERISATION | Non-Final OA | CAMBRIDGE ENTERPRISE LIMITED |
| 18580412 | COMPOSITIONS AND METHODS FOR DETECTION OF PANCREATIC CANCER | Non-Final OA | Mercy Bioanalytics, Inc. |
| 18269937 | ALK FUSION GENES AND USES THEREOF | Final Rejection | Foundation Medicine, Inc. |
| 17595263 | DEVICES AND METHODS FOR SAMPLE ANALYSIS | Final Rejection | Roche Sequencing Solutions, Inc |
| 17739978 | ASSAYS FOR SINGLE MOLECULE DETECTION AND USE THEREOF | Non-Final OA | Laboratory Corporation of America Holdings |
| 18709722 | METHYLATION SIGNATURES IN CELL-FREE DNA FOR TUMOR CLASSIFICATION AND EARLY DETECTION | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 17632519 | PROBE-INDUCED HETERODUPLEX MOBILITY ASSAY | Final Rejection | PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy